Cite
HARVARD Citation
He, M. et al. (n.d.). The predictive value of early changes in 18F-fluoroestradiol PET/CT during fulvestrant 500 mg therapy in patients with ER-positive metastatic breast cancer. Breast. pp. S58-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
He, M. et al. (n.d.). The predictive value of early changes in 18F-fluoroestradiol PET/CT during fulvestrant 500 mg therapy in patients with ER-positive metastatic breast cancer. Breast. pp. S58-. [Online].